Gabapentin (Neurontin)

Gabapentin (brand name Neurontin) is an anticonvulsant that is FDA-approved for partial seizures and for postherpetic neuralgia. Despite a name that nods to GABA, it does not meaningfully act on GABA receptors and is not converted into GABA in the body - its real target is a calcium-channel subunit, which is why it calms overactive nerve signaling. In neuro-ophthalmology its most distinctive role is steadying the eyes in acquired nystagmus and relieving the oscillopsia that makes the visual world appear to shake. These uses are off-label, supported by clinical trials rather than a formal FDA indication.

When the World Won't Hold Still

The neuro-ophthalmic reason to prescribe gabapentin is usually acquired pendular nystagmus (APN) - a smooth, sinusoidal back-and-forth movement of the eyes that, unlike a jerk nystagmus, has no fast and slow phase. APN most often arises from demyelinating disease such as multiple sclerosis, or as part of oculopalatal tremor after a brainstem stroke. Patients rarely complain of "nystagmus"; they complain that print swims on the page, that faces wobble, and that the world bounces when they try to hold their gaze - the symptom called oscillopsia. Randomized comparison studies have shown that gabapentin can reduce the amplitude of the oscillation, dampen oscillopsia, and improve visual acuity in a meaningful share of patients with APN, with memantine as the main alternative when gabapentin is not tolerated or not effective. The response is not universal, so a monitored trial is the way to find out whether it helps a given patient.

How Gabapentin Quiets Overactive Nerves

Gabapentin binds to the alpha-2-delta subunit of presynaptic voltage-gated calcium channels. By doing so it reduces calcium influx into nerve terminals and dials down the release of excitatory neurotransmitters such as glutamate. The result is reduced neuronal excitability in overactive circuits - whether those circuits are generating seizure activity, neuropathic pain signals, or the unstable eye-movement output that produces nystagmus. Importantly, it does not bind GABA receptors, is not a benzodiazepine, and does not work like baclofen, which is a true GABA-B agonist. Understanding this matters clinically: the two drugs are not interchangeable, and a patient who fails one may still respond to the other.

What We Use It For in Neuro-Ophthalmology

• Acquired pendular nystagmus and the oscillopsia that accompanies it
• Some other acquired nystagmus forms, such as downbeat or upbeat nystagmus, though the response is more variable and other agents are sometimes preferred
• Superior oblique myokymia as one of several medication options for this fluttering, shimmering monocular symptom
• Neuropathic and ocular surface pain, drawing on its established role in nerve-related pain

Congenital (infantile) nystagmus generally does not respond to gabapentin, so the drug is reserved for acquired conditions where the underlying circuitry has changed.

Dosing, Titration, and the Kidney Factor

Gabapentin is started low and built up gradually, both to limit drowsiness and because the body needs time to adjust.

• Starting dose: often 100-300 mg at bedtime
• Titration: increased every few days, typically toward 300-900 mg three times daily; higher totals are used for some indications
• Divided dosing helps absorption: gabapentin is absorbed by a saturable transporter in the gut, so its bioavailability actually falls as the single dose rises. Spreading the total across the day captures more of each dose than taking it all at once
• The kidney factor: gabapentin is eliminated unchanged by the kidneys and is not metabolized by the liver. Because of this, the dose must be reduced as kidney function declines - roughly stepping down as creatinine clearance falls below about 60, then 30, then 15 mL/min - and lower doses are used in older adults, who often have reduced clearance even with a normal-looking creatinine. Your prescriber sets the exact reduction

Side Effects

Most side effects reflect central nervous system slowing and tend to improve as the body adjusts or the dose is fine-tuned:

• Drowsiness, fatigue, and dizziness
• Unsteadiness and impaired coordination, which raises fall risk in older adults
• Cognitive slowing or word-finding difficulty
• Peripheral edema (ankle swelling) and weight gain
• Occasionally blurred or double vision and mood changes

Dependence and Controlled-Substance Status

Gabapentin is not a federally scheduled controlled substance, but a growing number of U.S. states have reclassified it as a Schedule V controlled substance or placed it under prescription-monitoring programs because of misuse potential, particularly when combined with opioids. With regular use the body can become physically dependent, and stopping abruptly can cause withdrawal - anxiety, insomnia, sweating, nausea, and, rarely, seizures. For both reasons gabapentin should be tapered rather than stopped suddenly, and it should be treated with the same care as any medication that acts on the nervous system.

Pregnancy and Breastfeeding

Human pregnancy data for gabapentin are limited. It crosses the placenta, and the decision to use it during pregnancy should be made with your obstetrician, balancing the benefit for your condition against the uncertainty in the safety data. Gabapentin does pass into breast milk, but measured infant blood levels are generally low; many clinicians consider breastfeeding compatible with monitoring of the infant for sedation or poor feeding. As with any nervous-system medication, do not start, stop, or change the dose around pregnancy without medical guidance.

Frequently Asked Questions

Why am I being given a seizure medicine for shaky vision?

Many anticonvulsants calm overexcitable circuits, and the unstable eye-movement output that causes acquired nystagmus behaves in some ways like that overexcitability. Gabapentin reduces the oscillation in a portion of patients, which steadies vision and relieves the sense that the world is moving. It is being used for its nerve-calming effect, not because you have epilepsy.

How long until I know whether it is helping my nystagmus?

Because the dose is increased gradually over weeks, allow that time before judging the result. Your doctor will look for steadier vision, less oscillopsia, and sometimes a measurable improvement in acuity, and may re-examine your eye movements. If a reasonable dose brings no benefit, the drug can be tapered and an alternative such as memantine considered.

Do I need blood tests on gabapentin?

There is no routine drug level to follow, but your doctor will pay attention to kidney function, since that determines the correct dose. Older adults and people with kidney disease need lower doses and closer follow-up.

Is gabapentin a narcotic or addictive?

It is not a narcotic (opioid), but it can cause physical dependence, and several states now monitor it as a controlled substance because some people misuse it. Used as prescribed it is generally safe; the key precautions are not combining it with other sedatives on your own and not stopping it abruptly.

Can I just stop it if it isn't working?

No - taper it under your doctor's guidance rather than stopping suddenly, to avoid withdrawal symptoms and, rarely, seizures. Your prescriber will provide a step-down schedule.